Maraviroc Tablet, Film Coated
Product Images NDC 73141-024

3 FDA label images from A2a Integrated Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 73141-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure.jpg.jpg (Chem Structure.jpg)

Chem-structure.jpg.jpg (Chem Structure.jpg)
Chemical structure of maraviroc, showing the molecular arrangement with fluorinated cyclohexane, phenyl, and triazole groups consistent with the drug's chemical identity.*
FDA Label Image

150mg-label (150mg Label)

150mg-label (150mg Label)
Label for Maraviroc Tablets 150 mg film-coated oral tablets, distributed by A2A Integrated Pharmaceuticals. The label states the quantity as 60 tablets, includes storage instructions, dosage notice, and a barcode. It also advises dispensing with a medication guide and warns against use if the safety seal is broken or missing.*
FDA Label Image

300mg-label (300mg Label)

300mg-label (300mg Label)
Label for Maraviroc Tablets 300 mg film-coated oral tablets, containing 60 tablets per container. The label includes storage instructions, dosage warning, and distributor information for A2A Integrated Pharmaceuticals. The product is prescription-only and directs users to dispense with a medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.